NIAID researchers make key discovery in development of TB drug candidate.
D000995:Antitubercular Agents / Q000494:pharmacology*; D015195:Drug Design; D024881:Drug Resistance, Bacterial; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics; D009316:National Institutes of Health (U.S.); D009593:Nitroimidazoles / Q000494:pharmacology*; D014481:United States
D000995:Antitubercular Agents; D009593:Nitroimidazoles; C410767:pretomanid